Amgen (NASDAQ: AMGN)
You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Amgen Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Amgen Company Info
One of the pioneers of the biotech industry, Amgen is now one of the world's largest pharmaceutical companies, with more than a dozen products focused on cancer, inflammation, neurology, cardiology, and more.
News & Analysis
2 Dow Jones Dividend Stocks to Buy Hand Over Fist Right Now
These two defensive dividend stocks sport compelling valuations and attractive yields.
Is This Dividend Stock a Screaming Buy After Its Latest Acquisition?
The biotech is ending the year with a bang.
Is Amgen Stock a Buy Now?
The company recently closed its acquisition of Horizon Therapeutics.
2 Dividend Growth Stocks to Buy Right Now
A wise man once said, be greedy when others are fearful.
2 Top Dividend Stocks to Buy in September
These two blue-chip dividend stocks have stood the test of time.
Is This the Green Light Biotech Stocks Have Been Waiting For?
It looks like the Federal Trade Commission will give up on its attempt to block Amgen's acquisition of Horizon Therapeutics.
Is Amgen Stock a Top Buy and Hold?
The biotech checks several important boxes for long-term shareholders.
Could Amgen Stock Help You Become a Millionaire?
Its pending acquisition of Horizon Therapeutics could make the company much bigger.
Valuation
Podcast Episodes
Why Amgen's Spending Billions to Buy This 1 Drug; Plus Heart Disease Has a New Enemy
Amgen is acquiring Otezla, and The Medicines Company unveils stellar data for its cholesterol treatment.
Why Amgen Can Deliver Medical and Financial Miracles
Its size, catalog, and pipeline give it strengths that are hard to beat.
Biotech Stocks Made Big Progress Toward Preventing Heart Attacks in 2018
Key trials suggest doctors may change how they treat patients with cardiovascular disease.
Healthcare Winners and Losers Following the AHCA's Failure
The failed attempt to repeal and replace Obamacare last month has big implications for healthcare investors.
Earnings Transcripts
Amgen Inc. (AMGN) Q3 2021 Earnings Call Transcript
AMGN earnings call for the period ending October 31, 2021.
Amgen inc (AMGN) Q2 2021 Earnings Call Transcript
AMGN earnings call for the period ending June 30, 2021.
Amgen Inc (AMGN) Q1 2021 Earnings Call Transcript
AMGN earnings call for the period ending March 31, 2021.
Amgen Inc (AMGN) Q4 2020 Earnings Call Transcript
AMGN earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.